All Stories

  1. Design, synthesis, and characterization of F-18 sigma-1 receptor radiotracers for Alzheimer disease

    Article • European Journal of Medicinal Chemistry, April 2026, Elsevier

    Ruiqing Ni

  2. In vivo measures of glutamate and the excitation/inhibition imbalance in brain disorders

    Article • Neural Regeneration Research, March 2026, Wolters Kluwer Health

    Ruiqing Ni

  3. Multimodal imaging-guided precise neuromodulation for Alzheimer’s disease

    Article • Neural Regeneration Research, March 2026, Wolters Kluwer Health

    Ruiqing Ni

  4. Targeting HSP90 in cancer: advances in the development of inhibitors, mechanisms of action, and therapeutic applications

    Article • Molecular Cancer, March 2026, Springer Science + Business Media

    Ruiqing Ni

  5. [18F]florbetapir PET for early detection of amyloidosis in patients with hereditary transthyretin amyloidosis polyneuropathy

    Article • Genes & Diseases, March 2026, Elsevier

    Ruiqing Ni

  6. Editorial: Update on the diagnosis, treatment, and research of cerebral cavernous malformations

    Article • Frontiers in Neurology, February 2026, Frontiers

    Ruiqing Ni

  7. Brain Extracellular Space: From an Overlooked Dimension to Catalyst of a Novel Neuroscience Paradigm

    Article • Cyborg and Bionic Systems, January 2026, American Association for the Advancement of Science

    Ruiqing Ni

  8. Integration of functional magnetic resonance imaging and artificial intelligence in Alzheimer’s disease

    Article • Neural Regeneration Research, January 2026, Wolters Kluwer Health

    Ruiqing Ni

  9. Enhanced ex vivo 3D whole-brain mapping and automated analysis of Parkinson’s disease pathologies in mice

    Article • December 2025, openRxiv

    Ruiqing Ni

  10. Noninvasive imaging of amyloid‐beta and tau in rodent and nonhuman primate models

    Article • View, December 2025, Wiley

    Ruiqing Ni

  11. Plasma growth-associated protein 43 correlates with synaptic loss in Alzheimer’s disease

    Article • Cell Reports Medicine, December 2025, Elsevier

    Ruiqing Ni

  12. Investigating the Association Between P2Y12 Receptor, SV2A, and Tau Expression in Postmortem AD and Control Brains Using In Vitro Autoradiography

    Article • Alzheimer s & Dementia, December 2025, Wiley

    Ruiqing Ni

  13. Multi‐scale imaging of α‐synuclein, dopamingeric neurodegeneration and microstructural changes in α‐synuclein PFF mouse model of Parkinson's disease

    Article • Alzheimer s & Dementia, December 2025, Wiley

    Ruiqing Ni

  14. Increased levels of GFAP and purinergic P2X7 receptor in Alzheimer’s disease brain are associated with Aβ, tau pathologies and synaptic loss

    Article • Alzheimer s Research & Therapy, November 2025, Springer Science + Business Media

    Ruiqing Ni

  15. Transcranial pulse stimulation modulates neuronal activity and functional network dynamics

    Article • Brain Stimulation, November 2025, Elsevier

    Ruiqing Ni

  16. Chemerin-CMKLR1 differentially mediated OGD/R-induced mitochondrial dysfunction, oxidative stress, and autophagy in microglia and neurons

    Article • Biomedicine & Pharmacotherapy, November 2025, Elsevier

    Ruiqing Ni

  17. Discerning Amyloid-β and Tau Pathologies with Learning-Based Quantum Sensing

    Article • ACS Photonics, September 2025, American Chemical Society (ACS)

    Ruiqing Ni

  18. Non-invasive large-scale imaging of concurrent neuronal, astrocytic, and hemodynamic activity with hybrid multiplexed fluorescence and magnetic resonance imaging (HyFMRI)

    Article • Light Science & Applications, September 2025, Springer Science + Business Media

    Ruiqing Ni

  19. Reduced synaptic vesicle protein 2A in extracellular vesicles and brains of Alzheimer’s disease: associations with Aβ, tau, synaptic proteins and APOE ε4

    Article • Translational Neurodegeneration, September 2025, Springer Science + Business Media

    Ruiqing Ni

  20. Spinal cord imaging in preclinical research

    Article • Neural Regeneration Research, September 2025, Wolters Kluwer Health

    Ruiqing Ni

  21. Isoliquiritigenin attenuated cognitive impairment, cerebral tau phosphorylation and oxidative stress in a streptozotocin-induced mouse model of Alzheimer's disease

    Article • Life Sciences, September 2025, Elsevier

    Ruiqing Ni

  22. Head-to-head comparison of [18F]florbetapir and [18F]FDG PET for the early detection of amyloidosis in systemic amyloidosis and plasma cell dyscrasias

    Article • European Journal of Radiology, August 2025, Elsevier

    Ruiqing Ni

  23. Synthesis and in vivo biological characterization of six carbon-11 sigma-1 receptor radiotracers in rodent and nonhuman primate

    Article • Bioorganic & Medicinal Chemistry, August 2025, Elsevier

    Ruiqing Ni

  24. Chemerin-CMKLR1 mediated OGD/R induced Mitochondrial Dysfunction, Oxidative Stress, and Autophagy differentially in Microglia and Neurons

    Article • July 2025, Cold Spring Harbor Laboratory Press

    Ruiqing Ni

  25. Synaptic loss pattern is constrained by brain connectome and modulated by phosphorylated tau in Alzheimer’s disease

    Article • Nature Communications, July 2025, Springer Science + Business Media

    Ruiqing Ni

  26. Prediction of longitudinal synaptic loss in Alzheimer's disease using tau PET and plasma biomarkers

    Article • Alzheimer s & Dementia, May 2025, Wiley

    Ruiqing Ni

  27. Imaging alpha-synuclein pathology in Parkinson’s disease

    Article • Neural Regeneration Research, February 2025, Wolters Kluwer Health

    Ruiqing Ni

  28. Tau pathology is associated with postsynaptic metabotropic glutamate receptor 5 (mGluR5) in early Alzheimer's disease in a sex‐specific manner

    Article • Alzheimer s & Dementia, February 2025, Wiley

    Ruiqing Ni

  29. Multimodal imaging of murine cerebrovascular dynamics induced by transcranial pulse stimulation

    Article • Alzheimer s & Dementia, January 2025, Wiley

    Ruiqing Ni

  30. Biomarkers for synaptic dysfunction in Alzheimer’s disease

    Article • Neural Regeneration Research, January 2025, Wolters Kluwer Health

    Ruiqing Ni

  31. Applications of Positron Emission Tomography (PET) in Preclinical Research

    Article • January 2025, Springer Science + Business Media

    Ruiqing Ni

  32. Distinguishing Alzheimer’s Pathologies with Machine Learning-Aided Quantum Sensing

    Article • January 2025, Optical Society of America (OSA)

    Ruiqing Ni

  33. Hybrid fluorescence and magnetic resonance imaging (HyFMRI) platform for functional neuroimaging

    Article • January 2025, Optical Society of America (OSA)

    Ruiqing Ni

  34. Development of a novel radioiodinated compound for amyloid and tau deposition imaging in Alzheimer's disease and tauopathy mouse models

    Article • NeuroImage, December 2024, Elsevier

    Ruiqing Ni

  35. Imaging of amyloid, tau and synaptic dysfunction in the brains of type 2 diabetic rats ‐ a multitracer PET study

    Article • Alzheimer s & Dementia, December 2024, Wiley

    Ruiqing Ni

  36. mTOR inhibition alleviated tau phosphorylation-induced mitochondrial impairment, oxidative stress, and cognitive impairment

    Article • November 2024, Cold Spring Harbor Laboratory Press

    Ruiqing Ni

  37. Spiral volumetric optoacoustic tomography of reduced oxygen saturation in the spinal cord of M83 mouse model of Parkinson’s disease

    Article • European Journal of Pediatrics, October 2024, Springer Science + Business Media

    Ruiqing Ni

  38. Myricetin ameliorates cognitive impairment in 3×Tg Alzheimer’s disease mice by regulating oxidative stress and tau hyperphosphorylation

    Article • Biomedicine & Pharmacotherapy, August 2024, Elsevier

    Ruiqing Ni

  39. Effect of APOE ɛ4 Status on Brain Amyloid‐β and Cognitive Function in Amnestic and Nonamnestic Mild Cognitive Impairment: A [18F] Florbetapir PET‐CT Study

    Article • Advanced Therapeutics, July 2024, Wiley

    Ruiqing Ni

  40. Visualizing alpha‐synuclein and iron deposition in M83 mouse model of Parkinson's disease in vivo

    Article • Brain Pathology, July 2024, Wiley

    Ruiqing Ni

  41. Efficient characterization of multiple binding sites of small molecule imaging ligands on amyloid-beta, tau and alpha-synuclein

    Article • European Journal of Pediatrics, July 2024, Springer Science + Business Media

    Ruiqing Ni

  42. Gastrodin ameliorates synaptic impairment, mitochondrial dysfunction and oxidative stress in N2a/APP cells

    Article • Biochemical and Biophysical Research Communications, July 2024, Elsevier

    Ruiqing Ni

  43. In vivo reactive astrocyte imaging using [18F]SMBT-1 in tauopathy and familial Alzheimer's disease mouse models: A multi-tracer study

    Article • Journal of the Neurological Sciences, July 2024, Elsevier

    Ruiqing Ni

  44. Increased Cerebral Level of P2X7R in a Tauopathy Mouse Model by PET Using [18F]GSK1482160

    Article • ACS Chemical Neuroscience, May 2024, American Chemical Society (ACS)

    Ruiqing Ni

  45. Presynaptic density determined by SV2A PET is closely associated with postsynaptic metabotropic glutamate receptor 5 availability and independent of amyloid pathology in early cognitive impairment

    Article • Alzheimer s & Dementia, April 2024, Wiley

    Ruiqing Ni

  46. Relationship Between Reactive Astrocytes, by [18F]SMBT-1 Imaging, with Amyloid-Beta, Tau, Glucose Metabolism, and TSPO in Mouse Models of Alzheimer’s Disease

    Article • Molecular Neurobiology, March 2024, Springer Science + Business Media

    Ruiqing Ni

  47. Reduced SV2A and GABAA receptor levels in the brains of type 2 diabetic rats revealed by [18F]SDM-8 and [18F]flumazenil PET

    Article • Biomedicine & Pharmacotherapy, March 2024, Elsevier

    Ruiqing Ni

  48. NRF2 Deficiency Promotes Ferroptosis of Astrocytes Mediated by Oxidative Stress in Alzheimer’s Disease

    Article • Molecular Neurobiology, February 2024, Springer Science + Business Media

    Ruiqing Ni

  49. Increased regional P2X7R uptake detected by [18F]GSK1482160 PET in a tauopathy mouse model

    Article • January 2024, Cold Spring Harbor Laboratory Press

    Ruiqing Ni

  50. Advances in non-invasive imaging of proteinopathies in animal models of neurodegenerative diseases

    Article • Neural Regeneration Research, January 2024, Wolters Kluwer Health

    Ruiqing Ni

  51. Noninvasive Visualization of Amyloid-Beta Deposits in Alzheimer’s Amyloidosis Mice via Fluorescence Molecular Tomography Using Contrast Agent

    Article • January 2024, Springer Science + Business Media

    Ruiqing Ni

  52. Probing Chemical Complexity of Amyloid Plaques in Alzheimer’s Disease Mice using Hyperspectral Raman Imaging

    Article • ACS Chemical Neuroscience, December 2023, American Chemical Society (ACS)

    Ruiqing Ni

  53. Relationship between reactive astrocytes, by [18F]SMBT-1 imaging, with amyloid-beta, tau, glucose metabolism, and microgliosis in mouse models of Alzheimer’s disease

    Article • August 2023, Cold Spring Harbor Laboratory Press

    Ruiqing Ni

  54. Imaging increased metabolism in the spinal cord in mice after middle cerebral artery occlusion

    Article • Photoacoustics, August 2023, Elsevier

    Ruiqing Ni

  55. Inorganic phosphate exporter heterozygosity in mice leads to brain vascular calcification, microangiopathy, and microgliosis

    Article • Brain Pathology, July 2023, Wiley

    Ruiqing Ni

  56. Collection on molecular imaging in neurodegeneration

    Article • European Journal of Pediatrics, July 2023, Springer Science + Business Media

    Ruiqing Ni

  57. Visualizing alpha-synuclein and iron deposition in M83 mouse model of Parkinson’s diseasein vivo

    Article • June 2023, Cold Spring Harbor Laboratory Press

    Ruiqing Ni

  58. Deep optoacoustic localization microangiography of ischemic stroke in mice

    Article • Nature Communications, June 2023, Springer Science + Business Media

    Mohamad Amki, Ruiqing Ni

  59. Evaluation of novel anti-CEACAM6 antibody-based conjugates for radioimmunotheranostics of pancreatic ductal adenocarcinoma

    Article • European Radiology, May 2023, Springer Science + Business Media

    Ruiqing Ni

  60. Aquaporin 4 is differentially increased and dislocated in association with tau and amyloid-beta

    Article • Life Sciences, May 2023, Elsevier

    Ruiqing Ni

  61. Efficient characterization of multiple binding sites of small molecule imaging ligands on amyloid-beta, 4-repeat/full-length tau and alpha-synuclein

    Article • March 2023, Cold Spring Harbor Laboratory Press

    Ruiqing Ni

  62. NRF2 deficiency promotes ferroptosis of astrocytes mediated by oxidative stress in Alzheimer’s disease

    Article • March 2023, Cold Spring Harbor Laboratory Press

    Ruiqing Ni

  63. Automatic analysis of skull thickness, scalp-to-cortex distance and association with age and sex in cognitively normal elderly

    Article • Brain Stimulation, March 2023, Elsevier

    Ruiqing Ni

  64. Monitoring mouse brain perfusion with hybrid magnetic resonance optoacoustic tomography

    Article • Biomedical Optics Express, February 2023, Optical Society of America (OSA)

    Ruiqing Ni

  65. PET imaging in animal models of Parkinson’s disease

    Article • Behavioural Brain Research, February 2023, Elsevier

    Ruiqing Ni

  66. Coregistered transcranial optoacoustic and magnetic resonance angiography of the human brain

    Article • Optics Letters, January 2023, Optical Society of America (OSA)

    Ruiqing Ni

  67. Automatic analysis of skull thickness, scalp-to-cortex distance and association with age and sex in cognitively normal elderly

    Article • January 2023, Cold Spring Harbor Laboratory Press

    Ruiqing Ni

  68. Gastrodin ameliorates synaptic impairment, reestablishes mitochondrial membrane potential and reduces oxidative stress in N2a/APP cells through ERK1/2 and GSK-3β pathways

    Article • January 2023, Cold Spring Harbor Laboratory Press

    Ruiqing Ni

  69. ChemR23 signaling ameliorates cognitive impairments in diabetic mice via dampening oxidative stress and NLRP3 inflammasome activation

    Article • Redox Biology, December 2022, Elsevier

    Ruiqing Ni

  70. Simultaneous Functional Magnetic Resonance and Optoacoustic Imaging of Brain‐Wide Sensory Responses in Mice

    Article • Advanced Science, November 2022, Wiley

    Ruiqing Ni

  71. Hybrid magnetic resonance and optoacoustic tomography (MROT) for preclinical neuroimaging

    Article • Light Science & Applications, November 2022, Springer Science + Business Media

    Ruiqing Ni

  72. Automatic image registration of optoacoustic tomography and magnetic resonance imaging based on deep learning

    Article • October 2022, SPIE

    Ruiqing Ni

  73. Evaluation of cannabinoid type 2 receptor expression and pyridine-based radiotracers in brains from a mouse model of Alzheimer’s disease

    Article • Frontiers in Aging Neuroscience, September 2022, Frontiers

    Ruiqing Ni

  74. Quercetin reduces APP expression, oxidative stress and mitochondrial dysfunction in the N2a/APPswe cells via ERK1/2 and AKT pathways

    Article • September 2022, Cold Spring Harbor Laboratory Press

    Ruiqing Ni

  75. Deep learning facilitates fully automated brain image registration of optoacoustic tomography and magnetic resonance imaging

    Article • Biomedical Optics Express, August 2022, Optical Society of America (OSA)

    Ruiqing Ni

  76. Sensitive ultrawideband transparent PVDF-ITO ultrasound detector for optoacoustic microscopy

    Article • Optics Letters, August 2022, Optical Society of America (OSA)

    Ruiqing Ni

  77. Multimodal Noninvasive Functional Neurophotonic Imaging of Murine Brain‐Wide Sensory Responses (Adv. Sci. 24/2022)

    Article • Advanced Science, August 2022, Wiley

    Ruiqing Ni

  78. Evaluation of CB2R expression and pyridine-based radiotracers in brains from a mouse model of Alzheimer’s disease

    Article • July 2022, Cold Spring Harbor Laboratory Press

    Ruiqing Ni

  79. Multiscale optical and optoacoustic imaging of amyloid-β deposits in mice

    Article • Nature Biomedical Engineering, July 2022, Springer Science + Business Media

    Ruiqing Ni

  80. Editorial: Translational imaging in neurodegenerative proteinopathies

    Article • Frontiers in Neuroscience, July 2022, Frontiers

    Ruiqing Ni

  81. Multimodal Noninvasive Functional Neurophotonic Imaging of Murine Brain‐Wide Sensory Responses

    Article • Advanced Science, July 2022, Wiley

    Ruiqing Ni

  82. Non-invasive visualization of amyloid-beta deposits in Alzheimer amyloidosis mice using magnetic resonance imaging and fluorescence molecular tomography

    Article • Biomedical Optics Express, June 2022, Optical Society of America (OSA)

    Ruiqing Ni

  83. Noninvasive optoacoustic imaging of the human brain validated with magnetic resonance angiography

    Article • May 2022, SPIE

    Ruiqing Ni

  84. Structural MRI Reveals Cervical Spinal Cord Atrophy in the P301L Mouse Model of Tauopathy: Gender and Transgene-Dosing Effects

    Article • Frontiers in Aging Neuroscience, May 2022, Frontiers

    Ruiqing Ni

  85. Amyloid and Tau Positron Emission Tomography Imaging in Alzheimer’s Disease and Other Tauopathies

    Article • Frontiers in Aging Neuroscience, April 2022, Frontiers

    Ruiqing Ni

  86. Recent Technical Advances in Accelerating the Clinical Translation of Small Animal Brain Imaging: Hybrid Imaging, Deep Learning, and Transcriptomics

    Article • Frontiers in Medicine, March 2022, Frontiers

    Ruiqing Ni

  87. Non-invasive imaging of tau-targeted probe uptake by whole brain multi-spectral optoacoustic tomography

    Article • European Journal of Pediatrics, February 2022, Springer Science + Business Media

    Ruiqing Ni

  88. Emodin Protects SH-SY5Y Cells Against Zinc-Induced Synaptic Impairment and Oxidative Stress Through the ERK1/2 Pathway

    Article • Frontiers in Pharmacology, February 2022, Frontiers

    Ruiqing Ni

  89. Rapamycin Attenuated Zinc-Induced Tau Phosphorylation and Oxidative Stress in Rats: Involvement of Dual mTOR/p70S6K and Nrf2/HO-1 Pathways

    Article • Frontiers in Immunology, February 2022, Frontiers

    Ruiqing Ni

  90. The Impact of Uremic Toxins on Alzheimer's Disease

    Article • Current Alzheimer Research, February 2022, Bentham Science Publishers

    Ruiqing Ni

  91. Magnetic Resonance Imaging in Tauopathy Animal Models

    Article • Frontiers in Aging Neuroscience, January 2022, Frontiers

    Ruiqing Ni

  92. Positron Emission Tomography in Animal Models of Tauopathies

    Article • Frontiers in Aging Neuroscience, January 2022, Frontiers

    Ruiqing Ni

  93. Recent Developments in Positron Emission Tomography Tracers for Proteinopathies Imaging in Dementia

    Article • Frontiers in Aging Neuroscience, January 2022, Frontiers

    Ruiqing Ni

  94. Evaluation of Transcranial Optoacoustic Imaging of a Human Brain Phantom

    Article • January 2022, Optical Society of America (OSA)

    Ruiqing Ni

  95. High‐resolution non‐invasive whole brain imaging of tauopathy in a tauopathy mouse model

    Article • Alzheimer s & Dementia, December 2021, Wiley

    Ruiqing Ni

  96. Arterial spin labeling demonstrates preserved regional cerebral blood flow in the P301L mouse model of tauopathy

    Article • Journal of Cerebral Blood Flow & Metabolism, November 2021, SAGE Publications

    Ruiqing Ni

  97. Magnetic Resonance Imaging in Animal Models of Alzheimer’s Disease Amyloidosis

    Article • International Journal of Molecular Sciences, November 2021, MDPI AG

    Ruiqing Ni

  98. Positron Emission Tomography in Animal Models of Alzheimer’s Disease Amyloidosis: Translational Implications

    Article • Pharmaceuticals, November 2021, MDPI AG

    Ruiqing Ni

  99. In vivo Imaging of Cannabinoid Type 2 Receptors: Functional and Structural Alterations in Mouse Model of Cerebral Ischemia by PET and MRI

    Article • Molecular Imaging and Biology, October 2021, Springer Science + Business Media

    Ruiqing Ni

  100. Multimodal Contrast Agents for Optoacoustic Brain Imaging in Small Animals

    Article • Frontiers in Bioengineering and Biotechnology, September 2021, Frontiers

    Ruiqing Ni

  101. PET Imaging of Neuroinflammation in Alzheimer’s Disease

    Article • Frontiers in Immunology, September 2021, Frontiers

    Ruiqing Ni

  102. In-vitro and in-vivo characterization of CRANAD-2 for multi-spectral optoacoustic tomography and fluorescence imaging of amyloid-beta deposits in Alzheimer mice

    Article • Photoacoustics, September 2021, Elsevier

    Ruiqing Ni

  103. The Synaptic Vesicle Protein 2A Interacts With Key Pathogenic Factors in Alzheimer’s Disease: Implications for Treatment

    Article • Frontiers in Cell and Developmental Biology, July 2021, Frontiers

    Ruiqing Ni

  104. Real-World Outcomes of Revascularization Strategies in Patients With Left Ventricular Dysfunction and Three-Vessel Coronary Disease Stratified by Mitral Regurgitation

    Article • Frontiers in Cardiovascular Medicine, June 2021, Frontiers

    Ruiqing Ni

  105. In vitro Characterization of the Regional Binding Distribution of Amyloid PET Tracer Florbetaben and the Glia Tracers Deprenyl and PK11195 in Autopsy Alzheimer’s Brain Tissue

    Article • Journal of Alzheimer’s Disease, April 2021, IOS Press

    Ruiqing Ni

  106. In vivo localization optoacoustic tomography (LOT) with particles smaller than red blood cells

    Article • March 2021, SPIE

    Ruiqing Ni

  107. Multi-scale optoacoustic molecular imaging of brain diseases

    Article • European Journal of Pediatrics, February 2021, Springer Science + Business Media

    Ruiqing Ni

  108. Non-invasive optoacoustic imaging of tau in P301L mice

    Article • January 2021, Optical Society of America (OSA)

    Ruiqing Ni

  109. Transcranial detection of amyloid‐beta at single plaque resolution in vivo with large‐field multifocal illumination fluorescence microscopy

    Article • Alzheimer s & Dementia, December 2020, Wiley

    Ruiqing Ni

  110. Transcranial detection of tauopathy in vivo in P301L mice with high‐resolution large‐field multifocal illumination fluorescence microscopy

    Article • Alzheimer s & Dementia, December 2020, Wiley

    Ruiqing Ni

  111. Volumetric multispectral optoacoustic tomography of beta‐amyloid deposits in whole mouse brain

    Article • Alzheimer s & Dementia, December 2020, Wiley

    Ruiqing Ni

  112. Detection of cerebral tauopathy in P301L mice using high-resolution large-field multifocal illumination fluorescence microscopy

    Article • Biomedical Optics Express, August 2020, Optical Society of America (OSA)

    Ruiqing Ni

  113. SWI and phase imaging reveal intracranial calcifications in the P301L mouse model of human tauopathy

    Article • Magnetic Resonance Materials in Physics Biology and Medicine, May 2020, Springer Science + Business Media

    Ruiqing Ni

  114. Whole brain optoacoustic tomography reveals strain-specific regional beta-amyloid densities in Alzheimer’s disease amyloidosis models

    Article • February 2020, Cold Spring Harbor Laboratory Press

    Ruiqing Ni

  115. Transcranial in vivo detection of amyloid-beta at single plaque resolution with large-field multifocal illumination fluorescence microscopy

    Article • February 2020, Cold Spring Harbor Laboratory Press

    Ruiqing Ni

  116. Diffusion Tensor Imaging Reveals Whole-Brain Microstructural Changes in the P301L Mouse Model of Tauopathy

    Article • Neurodegenerative Diseases, January 2020, Karger Publishers

    Ruiqing Ni

  117. Tau deposition is associated with imaging patterns of tissue calcification in the P301L mouse model of human tauopathy

    Article • November 2019, Cold Spring Harbor Laboratory Press

    Ruiqing Ni

  118. Simulation of fluorescence molecular tomography using a registered digital mouse atlas

    Article • July 2019, SPIE

    Ruiqing Ni

  119. Automated registration of magnetic resonance imaging and optoacoustic tomography data for experimental studies

    Article • Neurophotonics, April 2019, SPIE

    Ruiqing Ni

  120. International Photoacoustic Standardisation Consortium (IPASC): overview (Conference Presentation)

    Article • March 2019, SPIE

    Ruiqing Ni

  121. fMRI Reveals Mitigation of Cerebrovascular Dysfunction by Bradykinin Receptors 1 and 2 Inhibitor Noscapine in a Mouse Model of Cerebral Amyloidosis

    Article • Frontiers in Aging Neuroscience, February 2019, Frontiers

    Ruiqing Ni

  122. Automated registration for optoacoustic tomography and MRI

    Article • January 2019, Optical Society of America (OSA)

    Ruiqing Ni

  123. BRADYKININ ANTAGONIST NOSCAPINE MITIGATES CEREBROVASCULAR DYSFUNCTION IN THE ARCAβ MOUSE MODEL OF ALZHEIMER’S DISEASE

    Article • Alzheimer s & Dementia, July 2018, Elsevier

    Ruiqing Ni

  124. EVALUATION OF CANNABINOID RECEPTOR 2 PET IMAGING TRACERS IN ALZHEIMER’S DISEASE BRAIN

    Article • Alzheimer s & Dementia, July 2018, Elsevier

    Ruiqing Ni

  125. IN VIVO OPTOACOUSTIC TOMOGRAPHY OF BRAIN AMYLOID DEPOSITS IN AN ARCAβ MOUSE MODEL OF ALZHEIMER’S DISEASE

    Article • Alzheimer s & Dementia, July 2018, Elsevier

    Ruiqing Ni

  126. Positron emission tomography of type 2 cannabinoid receptors for detecting inflammation in the central nervous system

    Article • Acta Pharmacologica Sinica, June 2018, Springer Science + Business Media

    Ruiqing Ni

  127. Cortical hypoperfusion and reduced cerebral metabolic rate of oxygen in the arcAβ mouse model of Alzheimer’s disease

    Article • Photoacoustics, June 2018, Elsevier

    Ruiqing Ni

  128. Optimization of GERD Therapeutic Regimen Based on ANN and Realization of MATLAB

    Article • Digital Chinese Medicine, March 2018, Elsevier

    Ruiqing Ni

  129. Noninvasive detection of acute cerebral hypoxia and subsequent matrix-metalloproteinase activity in a mouse model of cerebral ischemia using multispectral-optoacoustic-tomography

    Article • Neurophotonics, February 2018, SPIE

    Ruiqing Ni

  130. Non-invasive detection of matrix-metalloproteinase activity in a mouse model of cerebral ischemia using multispectral optoacoustic tomography

    Article • February 2018, SPIE

    Ruiqing Ni

  131. Quantification of amyloid deposits and oxygen extraction fraction in the brain with multispectral optoacoustic imaging in arcAbeta mouse model of Alzheimer's disease

    Article • February 2018, SPIE

    Ruiqing Ni

  132. Comparative In Vitro and In Vivo Quantifications of Pathologic Tau Deposits and Their Association with Neurodegeneration in Tauopathy Mouse Models

    Article • Journal of Nuclear Medicine, February 2018, Society of Nuclear Medicine

    Ruiqing Ni

  133. In Vivo Visualization of Tau Accumulation, Microglial Activation, and Brain Atrophy in a Mouse Model of Tauopathy rTg4510

    Article • Journal of Alzheimer’s Disease, January 2018, IOS Press

    Naruhiko Sahara, Ruiqing Ni

  134. Psychological and neural mechanisms of rotating leadership in teams: the impact of engagement and shared mental model

    Article • European Neuropsychopharmacology, October 2017, Elsevier

    Ruiqing Ni

  135. Amyloid tracers binding sites in autosomal dominant and sporadic Alzheimer's disease

    Article • Alzheimer s & Dementia, April 2017, Elsevier

    Ruiqing Ni

  136. Extracerebral Tissue Damage in the Intraluminal Filament Mouse Model of Middle Cerebral Artery Occlusion

    Article • Frontiers in Neurology, March 2017, Frontiers

    Ruiqing Ni

  137. Distinct binding of PET ligands PBB3 and AV-1451 to tau fibril strains in neurodegenerative tauopathies

    Article • Brain, January 2017, Oxford University Press (OUP)

    Ruiqing Ni

  138. P2‐257: Radioligand Binding Assays for Comparison of TAU Pet Probes, PBB3 and T807, in Detection of TAU Pathologies in Alzheimer's Disease and PSP Brains, and Neurotoxic TAU Species in a Transgenic Mouse Model

    Article • Alzheimer s & Dementia, July 2016, Wiley

    Ruiqing Ni

  139. P4‐254: Characterization of regional binding of clinical amyloid tracers in autosomal dominant and sporadic Alzheimer's disease brains and their interactions with resveratrol

    Article • Alzheimer s & Dementia, July 2015, Wiley

    Ruiqing Ni

  140. Astrocytosis precedes amyloid plaque deposition in Alzheimer APPswe transgenic mouse brain: a correlative positron emission tomography and in vitro imaging study

    Article • European Journal of Pediatrics, April 2015, Springer Science + Business Media

    Ruiqing Ni

  141. O4‐02‐05: DIFFERENT TIME COURSE OF ASTROCYTOSIS AND AMYLOID DEPOSITION IN ALZHEIMER'S APPSWE TRANSGENICE MICE: A MULTI‐TRACER MICROPET STUDY

    Article • Alzheimer s & Dementia, July 2014, Wiley

    Ruiqing Ni

  142. 3H-Deprenyl and 3H-PIB autoradiography show different laminar distributions of astroglia and fibrillar β-amyloid in Alzheimer brain

    Article • Journal of Neuroinflammation, July 2013, Springer Science + Business Media

    Ruiqing Ni

  143. O2–11–03: Astrocytosis precedes amyloid deposition in Alzheimer's Tg2576 APPswe transgenic mice: A multi‐tracer microPET imaging study

    Article • Alzheimer s & Dementia, July 2013, Wiley

    Ruiqing Ni

  144. IC‐P‐038: Astrocytosis precedes amyloid deposition in Alzheimer's disease Tg2576 APPswe transgenic mice: A multitracer microPET imaging study

    Article • Alzheimer s & Dementia, July 2013, Wiley

    Ruiqing Ni

  145. Amyloid tracers detect multiple binding sites in Alzheimer's disease brain tissue

    Article • Brain, June 2013, Oxford University Press (OUP)

    Ruiqing Ni

  146. Combination of 18F-FDG PET and Cerebrospinal Fluid Biomarkers as a Better Predictor of the Progression to Alzheimer's Disease in Mild Cognitive Impairment Patients

    Article • Journal of Alzheimer’s Disease, January 2013, IOS Press

    Ruiqing Ni

  147. Modulation of α7 Nicotinic Acetylcholine Receptor and Fibrillar Amyloid-β Interactions in Alzheimer's Disease Brain

    Article • Journal of Alzheimer’s Disease, January 2013, IOS Press

    Ruiqing Ni

  148. P2‐487: Alpha7 nicotinic receptor agonists interrupt the interaction between fibrillar amyloid and nicotinic receptor in Alzheimer's brain

    Article • Alzheimer s & Dementia, July 2011, Wiley

    Ruiqing Ni

  149. P4‐301: Evolution of fibrillar amyloid in relation to astro‐ and microgliosis and alterations in α7 nicotinic receptors in Alzheimer APPswe mice as studied with multi‐tracer concept

    Article • Alzheimer s & Dementia, July 2011, Wiley

    Ruiqing Ni

  150. P2‐329: Laminar distributions of fibrillar β‐amyloid and activated astrocytes in Alzheimer's disease autopsy brain: A quantitative autoradiography study

    Article • Alzheimer s & Dementia, July 2011, Wiley

    Ruiqing Ni

  151. P.1.002 Drug interaction between fibrillar amyloid β and alpha7 nicotinic receptor in Alzheimer brain

    Article • European Neuropsychopharmacology, March 2011, Elsevier

    Ruiqing Ni